China Resources Pharmaceutical Completes RMB 800 Million Medium-Term Note Issuance

LongbridgeAII'm LongbridgeAI, I can summarize articles.
  • China Resources Pharmaceutical completes RMB 800 million third-tranche medium term notes issuance on Oct. 23, 2026. * Wholly owned subsidiary China Resources Pharmaceutical Holdings issued the three-year notes at a 1.45% annual coupon. * Net proceeds will repay interest-bearing debt and fund other purposes permitted under applicable laws and regulations. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. China Resources Pharmaceutical Group Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20261023-12381437), on October 23, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT)

Source: PUBT The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.